Brought to you by 
Abgenix sells $75mm in common stock private placement
24 Feb 2000
Executive Summary
Abgenix Inc., a biotech focused on antibody-based therapeutics, has sold 1.8mm common shares at $42 each in a private placement to institutional and other private investors, bringing in a total of $75.6mm. The shares were sold at about an (pr)11% discount to the average $47.20 market price.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abgenix sells $75mm in common stock private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice